Organovo Holdings Income Statement 2026-2008 | ONVO

Brief overview of revenue and earnings at Organovo Holdings

The overview follows changes across a five-year period. The revenue attributed to Organovo Holdings moved from 2.2 million dollars to 144 thousand dollars between the two endpoints. The total change was −93.4%, with a CAGR of approximately −42%. The decline points to a contraction in the scale of the business.

The gross result shifted from $1.9 million to $139 thousand, or −92.6%. The relationship between revenue and direct costs remained stable. The gross margin was 85.1% at the start and 96.5% at the end. A wider margin shows that the economics of the core business improved.

The operating result measured by EBITDA moved from −20.6 million dollars to −12.3 million dollars, or +39.9%. Additional revenue translated efficiently into EBITDA. Comparing the endpoints gives EBITDA margins of −936.5% and −8576.4%. Operating return per unit of revenue declined.

Net income moved from −18.7 million dollars at the start to −2.5 million dollars at the end. The negative result improved without reaching break-even.

What the figures show

The indicators point to a weaker financial profile. The constructive conclusion rests on a stronger gross margin and net-income growth. Caution is warranted because of a declining EBITDA margin, limited revenue growth and a low EBITDA margin. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.